Home » Stocks » HJLI

Hancock Jaffe Laboratories, Inc. (HJLI)

Stock Price: $5.87 USD -0.19 (-3.14%)
Updated Apr 19, 2021 12:12 PM EDT - Market open
Market Cap 51.53M
Revenue (ttm) n/a
Net Income (ttm) -9.74M
Shares Out 1.29M
EPS (ttm) -7.54
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 19
Last Price $5.87
Previous Close $6.06
Change ($) -0.19
Change (%) -3.14%
Day's Open 6.06
Day's Range 5.86 - 6.13
Day's Volume 89,095
52-Week Range 5.55 - 20.25

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

IRVINE, CA / ACCESSWIRE / April 7, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the United States ...

1 week ago - Accesswire

IRVINE, CA / ACCESSWIRE / April 5, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the U.S. Food and ...

2 weeks ago - Accesswire

IRVINE, CA / ACCESSWIRE / March 8, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has submitted a...

1 month ago - Accesswire

Company to Move Forward with Application for VenoValve U.S. Pivotal Trial IRVINE, CA / ACCESSWIRE / January 12, 2021 /  Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices tha...

3 months ago - Accesswire

IRVINE, CA / ACCESSWIRE / December 30, 2020  / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that Dr. Hamed Ala...

3 months ago - Accesswire

Company Regains Compliance with NASDAQ Minimum Bid Requirement IRVINE, CA / ACCESSWIRE / December 21, 2020  / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore ...

3 months ago - Accesswire

About HJLI

Hancock Jaffe Laboratories, Inc., a medical device company, develops and sells tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It engages in the development and manufacture of bioprosthetic medical devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf... [Read more...]

Industry
Medical Devices
Founded
1987
Stock Exchange
NASDAQ
Ticker Symbol
HJLI
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to one analyst, the rating for HJLI stock is "Strong Buy" and the 12-month stock price forecast is 28.00.

Price Target
$28.00
Analyst Consensus: Strong Buy